Announcements Trials
Browse Landscape

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Polycystic Ovary Syndrome 1Motor Activity 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hyperandrogenism 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Blood Pressure Monitoring, Ambulatory × Clear all
NCT03841981 2025-08-12

Body Fat as Determinant of Female Gonadal Dysfunction

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Recruiting
50 enrolled

Motor Activity, Polycystic Ovary Syndrome, Hyperandrogenism

NCT05521178 2024-10-15

Cardiotoxicities in Patients Receiving BTKi

Dana-Farber Cancer Institute

Withdrawn
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡